One Eleven Interactive, Inc

Innovative marketing programs for the pharmaceutical industry

One Eleven Interactive, Inc Pharmaceuticals Turing Pharmaceuticals to offer stock buyback program for stockholders

Turing Pharmaceuticals to offer stock buyback program for stockholders

Turing pharmaceutical company Marinus Pharmaceuticals has announced that it will offer stockbuyback programs for stockholder buybacks of up to 30% of the company’s shares during a period of three years, as part of its ongoing strategic review and restructuring plan.

This will allow shareholders to purchase back shares of the Company in a manner similar to that of a stock purchase program. 

The program will be conducted through a third-party buyback advisor, and will begin in 2018. 

 Marinus will offer buyback programs with buyback offers up to 10% of their company’s stock price, subject to approval by Marinus shareholders. 

For more information, please contact:  Dan Stebbing, Vice President of Investor Relations and Corporate Communications, at [email protected] 

Read more articles by Dan Stebling Read our business section, our consumer section or our news section for the latest on the world of finance. 

About Engadge:Engadge is a leading content marketing platform that helps businesses connect with their customers and deliver better value by building brand awareness and understanding.

Engadges unique platform is powered by its comprehensive customer-facing platform, Engadged, a full-featured analytics platform, and the award-winning Engadging App, which delivers real-time insights and data insights.

Engaged brands can now leverage Engadgets insights, including custom emails, customized search queries, and interactive maps, to reach customers in new ways.

Engads product lineup includes brand content, marketing tools, and ecommerce solutions.

Engadges mission is to help businesses succeed by making it easy for people to do their job better.

Engage customers, partners and employees in ways that are best for their organizations.

For more information visit: or contact [email protected]

TopBack to Top